Activity of N-lutidinylarylcarboxamides against Leishmania donovani and L. braziliensis

Acta Parasitologica

Volumn 44, Issue 3, 1999, Pages 156-159

  Le Pape, Patrice ^a   Abdala, Hiam ^a   Pagniez, Fabrice ^a   Robert, Jean Michel ^a   Le Baut, Guillaume ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Arylcarboxamides; L. braziliensis; Leishmania donovani

Indexed keywords

EID: 0032697081     PISSN: 12302821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Achterberg V., Gercken G. 1987. Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes. Molecular and Biochemical Parasitology, 23, 117-122.
2. Aderem A. A., Scott W. A., Cohn Z. A. 1986. Evidence for sequential signals in the induction of arachidonic acid cascade in macrophages. Journal of Experimental Medicine, 163, 139-154.
3. 2 from Trypanosoma congolense: Characterization and hematological properties. Cellular Biochemistry and Function, 11, 125-130.
4. Berman J. D. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical and Infectious Diseases, 24, 684-703.
5. Buffet P., Sulahian A. A., Garin J. F., Nassar N., Derouin F. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrobial Agents and Chemotherapy, 39, 2167-2168.
6. 2 - sensitive components of the parasite membrane. Biochemical and Biophysical Research Community, 121, 931-939.
7. Croft S. L. 1988. Recent development in the chemotherapy of leishmaniasis. Trends in Pharmacology Science, 9, 376-381.
8. Croft S. L., Neal R. A., Herrmann D. B. J. 1993. Antileishmania activity of the ether phospholipid ilmofosine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 217-219.
9. Croft S. L., Neal R. A., Pendergast W., Chan H. 1987. The activity of alkyl phosphorylcholines and related derivates against Leishmania donovani. Biochemical Pharmacology, 36, 2633-2636.
10. Davidson R. N., Croft S. L. 1993. Recent advances in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 130-131.
11. 2. Journal of Biological Chemistry, 269, 13057-13060.
12. Hill J. O., North R. J., Collins F. M. 1983. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infection and Immunity, 39, 1087-1094.
13. 2 activation by phosphorylation in mouse peritoneal macrophages. Journal of Biological Chemistry, 268, 24506-24513.
14. Lujan H. D., Bronia D. H. 1994. Intermembrane lipid transfer during Trypanosoma cruzi-induced erythrocyte membrane destabilization. Parasitology, 108, 323-334.
15. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Journal of Immunological Methods, 65, 55-63.
16. Peter W. 1988. Morphology. In: Parasitology in focus. Facts and trends (Ed. H. Mehlhorn). Springer-Verlag, Berlin, Heidelberg, 161-221.
17. Raffi F, Merrien D., Le Pape P., Reliquet V. 1995. Use of an itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clinical and Infectious Diseases, 21, 1338-1339.
18. Robert-Piessard S., Le Baut G., Courant J., Brion J. D., Sparfel L., Bouhayat S., Petit J. Y., Sanchez R. Y., Juge M., Grimaud N., Welin L. 1990. Non-acidic anti-inflammatory compounds: Activity of N-(4,6-dimethyl-2-pyridinyl)benzamides and derivates. European Journal of Medical Chemistry, 25, 9-19.
19. Van Den Bossche H. 1980. Intracellular phospholipase A. Biochimica et Biophysica Acta, 604, 191-246.
20. 2 by chloroquine, quinine, and arteether. Journal of Parasitology, 79, 565-570.
21. Zidane M., Moré M. T., Marjolet M., Le Pape P. 1995. In vitro activity of a glycoprotein of the sponge Pachymastisma johnstonni against Leishmania donovani promastigotes. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. ICAAC, San Francisco.